GHX provides a wide range of perspectives on how greater collaboration and visibility across the supply chain can improve both clinical and financial performance in healthcare.
As health systems prioritize resiliency, sustainability and equity, value analysis teams must consider an expanding list of factors beyond cost and quality. From the impacts of climate change to reducing health disparities, Karen Conway, MSc, CMRP, met with a panel of industry leaders to discuss future considerations for healthcare value analysis teams. Read on to learn about their key takeaways and insights into how value analysis and strategic sourcing professionals can support sustainable, affordable and equitable care.
***
I had the honor recently to moderate a panel with three esteemed industry leaders (and friends):
In case you missed the session, entitled From Equity and the Environment to Resiliency and Risk Management: Future Considerations for Healthcare Value analysis Teams, we will continue the discussion in May at GHX Summit 2023 in Chicago.
We explored how value analysis and strategic sourcing professionals will need to consider an evolving and expanding list of factors as healthcare systems prioritize resiliency, sustainability and equity, in addition to cost and quality. All these factors play important roles as we work to provide more affordable, accessible and equitable healthcare for all.
Here are a few key takeaways from our discussion:
Equity, the environment and risk management are all critical considerations for value analysis and strategic sourcing teams. By understanding the impact of these factors on care delivery, we can help ensure that hospitals are sourcing the most appropriate products to support sustainable, affordable, and equitable care.
This blog only touches on what the four of us covered throughout our conversation. You, too, can join the conversation by watching the webinar.